AAPA Advocacy staff spoke to CVS Caremark Corporation and CVS Health regarding recent rejection of PA prescriptions by CVS pharmacies. AAPA confirmed that there will be no further disruption in service for PAs and their patients.
Missouri PAs are celebrating the recent enactment of two important bills which will increase access for patients in need of psychiatric care and treatment for opioid use disorder (OUD), and reduce administrative barriers faced by PAs serving rural and underserved populations.
PAs in Rhode Island will have greater ability to authorize care for their patients thanks to the enactment of two new laws. These important changes were the product of a collaborative effort between the RIAPA and the Rhode Island State Nurses Association.
On Friday, June 22, 2018, the U.S. House of Representatives passed legislation that will permanently extend the waiver program that allows PAs to prescribe buprenorphine for treatment of opioid use disorder (OUD).
Oklahoma PAs are celebrating increased access to loan repayment and scholarship programs administered by the state’s Physician Manpower Training Commission, thanks to the enactment of a new law H.B. 2987.
Louisiana PAs are celebrating the enactment of a new law which removes an outdated requirement for prescriptive authority and increases the number of PAs with whom a physician may practice. Act 475 was signed on May 23, and becomes effective on August 1.